Qin Ryan

1.2k total citations
11 papers, 952 citations indexed

About

Qin Ryan is a scholar working on Molecular Biology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qin Ryan has authored 11 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Hematology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qin Ryan's work include Histone Deacetylase Inhibitors Research (4 papers), Protein Degradation and Inhibitors (3 papers) and Erythropoietin and Anemia Treatment (2 papers). Qin Ryan is often cited by papers focused on Histone Deacetylase Inhibitors Research (4 papers), Protein Degradation and Inhibitors (3 papers) and Erythropoietin and Anemia Treatment (2 papers). Qin Ryan collaborates with scholars based in United States and United Kingdom. Qin Ryan's co-authors include Robert Justice, Kyunghwa Hwang, Richard Pazdur, Amna Ibrahim, Chia‐Wen Ko, John R. Johnson, Rajeshwari Sridhara, Martin H. Cohen, Jane B. Trepel and Eun Joo Chung and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Qin Ryan

11 papers receiving 924 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qin Ryan United States	10	558	303	158	136	118	11	952
Daniel Mulkerin United States	18	366 0.7×	670 2.2×	209 1.3×	229 1.7×	121 1.0×	79	1.2k
Virginia E. Kwitkowski United States	16	484 0.9×	423 1.4×	119 0.8×	264 1.9×	108 0.9×	18	1.2k
François Wilhelm United States	16	270 0.5×	264 0.9×	220 1.4×	67 0.5×	75 0.6×	64	796
May Garrett United States	14	316 0.6×	266 0.9×	113 0.7×	376 2.8×	89 0.8×	23	665
Michael Xiang United States	16	475 0.9×	351 1.2×	104 0.7×	295 2.2×	102 0.9×	68	1.1k
Ann Marie Rossi United States	8	960 1.7×	403 1.3×	268 1.7×	105 0.8×	59 0.5×	11	1.3k
Alberto Bessudo United States	18	517 0.9×	609 2.0×	388 2.5×	105 0.8×	258 2.2×	70	1.2k
Lorrin Yee United States	17	446 0.8×	514 1.7×	134 0.8×	128 0.9×	55 0.5×	37	1.0k
Karel Eechoute Netherlands	12	356 0.6×	485 1.6×	173 1.1×	361 2.7×	110 0.9×	22	985
Ernesto Vigna Italy	15	296 0.5×	193 0.6×	316 2.0×	50 0.4×	178 1.5×	85	649

Countries citing papers authored by Qin Ryan

Since Specialization

Citations

This map shows the geographic impact of Qin Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qin Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qin Ryan more than expected).

Fields of papers citing papers by Qin Ryan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qin Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qin Ryan. The network helps show where Qin Ryan may publish in the future.

Co-authorship network of co-authors of Qin Ryan

This figure shows the co-authorship network connecting the top 25 collaborators of Qin Ryan. A scholar is included among the top collaborators of Qin Ryan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qin Ryan. Qin Ryan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Szarfman, Ana, Joseph M. Tonning, Frank Weichold, et al.. (2022). Recommendations for achieving interoperable and shareable medical data in the USA. SHILAP Revista de lepidopterología. 2(1). 86–86. 22 indexed citations

Zhang, Rongmei, Hui‐Lee Wong, Michael Wernecke, et al.. (2021). Trends in Erythropoiesis‐stimulating agent use and blood transfusions for chemotherapy‐induced anemia throughout FDA's risk evaluation and mitigation strategy lifecycle. Pharmacoepidemiology and Drug Safety. 30(5). 626–635. 1 indexed citations

Wang, Cunlin, Robert C. Kane, Mark Levenson, et al.. (2016). Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service Medicare. JAMA Internal Medicine. 176(12). 1818–1818. 25 indexed citations

Wang, Cunlin, David J. Graham, Robert C. Kane, et al.. (2015). Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products. JAMA. 314(19). 2062–2062. 151 indexed citations

Figg, William D., Manish Monga, Donna Headlee, et al.. (2014). A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms. Cancer Chemotherapy and Pharmacology. 74(5). 955–967. 15 indexed citations

Ryan, Qin, Amna Ibrahim, Martin H. Cohen, et al.. (2008). FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That Overexpresses HER-2. The Oncologist. 13(10). 1114–1119. 236 indexed citations

Kummar, Shivaani, Martin Gutierrez, Erin R. Gardner, et al.. (2007). Phase I Trial of MS-275, a Histone Deacetylase Inhibitor, Administered Weekly in Refractory Solid Tumors and Lymphoid Malignancies. Clinical Cancer Research. 13(18). 5411–5417. 107 indexed citations

Acharya, Milin, Judith E. Karp, Edward A. Sausville, et al.. (2006). Factors affecting the pharmacokinetic profile of MS-275, a novel histone deacetylase inhibitor, in patients with cancer. Investigational New Drugs. 24(5). 367–375. 19 indexed citations

Chung, Eun Joo, Sunmin Lee, Edward A. Sausville, et al.. (2005). Histone deacetylase inhibitor pharmacodynamic analysis by multiparameter flow cytometry.. PubMed. 35(4). 397–406. 19 indexed citations

10.

Ryan, Qin, Donna Headlee, Milin Acharya, et al.. (2005). Phase I and Pharmacokinetic Study of MS-275, a Histone Deacetylase Inhibitor, in Patients With Advanced and Refractory Solid Tumors or Lymphoma. Journal of Clinical Oncology. 23(17). 3912–3922. 344 indexed citations

11.

Carrasquillo, Jorge A., et al.. (2003). Fluorodeoxyglucose Positron Emission Tomography in the Presence of Cardiac Metastases. Clinical Nuclear Medicine. 28(12). 979–980. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact